Kidney News interviewed Jeff Ross, PhD, CEO of Miromatrix Medical, about the company’s work to bioengineer new kidney grafts consisting of human cells grown in pig extracellular matrix scaffolds. Ross presented the work, “Building New Kidneys,” at the inaugural KidneyX Summit in Washington, DC, on April 29, 2019.
KN: Why build new kidneys, and why now?
Dr. Ross The numbers are truly eye-opening—more than 700,000 Americans are living with kidney failure that requires dialysis or transplantation. Unfortunately, less than half of the patients who start dialysis will survive five years, while those fortunate to receive a kidney transplant